Condensed Consolidated Statements Of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
REVENUE (Note 16)	$ 146,818	$ 143,893	$ 292,364	$ 279,982
EXPENSE
Cost of goods sold, IT processing, servicing and support	101,298	114,266	212,185	221,756
Selling, general and administration	36,520	21,507	63,246	44,022
Depreciation and amortization	8,223	5,813	14,499	11,669
Transaction costs related to Adumo acquisition (Note 2)	0	34	1,702	34
OPERATING INCOME	777	2,273	732	2,501
CHANGE IN FAIR VALUE OF EQUITY SECURITIES (Note 5 and 6)	(33,731)	0	(33,731)	0
LOSS ON DISPOSAL OF EQUITY-ACCOUNTED INVESTMENT (Note 6)	161	0	161	0
REVERSAL OF ALLOWANCE FOR EMI DEBT RECEIVABLE	0	0	0	250
INTEREST INCOME	721	485	1,307	934
INTEREST EXPENSE	6,174	4,822	11,206	9,731
LOSS BEFORE INCOME TAX (BENEFIT) EXPENSE	(38,568)	(2,064)	(43,059)	(6,046)
INCOME TAX (BENEFIT) EXPENSE (Note 19)	(6,412)	686	(6,334)	950
NET LOSS BEFORE EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS	(32,156)	(2,750)	(36,725)	(6,996)
EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS (Note 6)	50	43	77	(1,362)
NET LOSS	(32,106)	(2,707)	(36,648)	(8,358)
LESS NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTEREST	28	0	28	0
NET LOSS ATTRIBUTABLE TO LESAKA	$ (32,134)	$ (2,707)	$ (36,676)	$ (8,358)
Net loss per share, in United States dollars (Note 14):
Basic loss attributable to Lesaka shareholders	$ (0.40)	$ (0.04)	$ (0.51)	$ (0.13)
Diluted loss attributable to Lesaka shareholders	$ (0.40)	$ (0.04)	$ (0.51)	$ (0.13)